10.5 C
Glasgow
Wednesday, April 8, 2026
spot_img
Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Positive results from moderate-to-severe atopic dermatitis trial

Enveda has announced positive phase 1b results for ENV-294, a first-in-class, oral, once-daily investigational therapy, in patients with moderate-to-severe atopic dermatitis (AD). The open-label study...